Invasive fungal infections (IFIs) have been identified as a complication in patients with Coronavirus disease 2019 (COVID‐19). To date, there are few US studies examining the excess humanistic and economic… Click to show full abstract
Invasive fungal infections (IFIs) have been identified as a complication in patients with Coronavirus disease 2019 (COVID‐19). To date, there are few US studies examining the excess humanistic and economic burden of IFIs on hospitalised COVID‐19 patients.
               
Click one of the above tabs to view related content.